‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address
In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science
Latest Statistics Show Decline In Deaths From Breast Cancer
“What Is Good For NCI Is Good For NIH,” Broder Says In Address
Proposed Deal Could Resolve Key Disputes At NSABP, Pitt
NIH Reconsiders Closing A Meeting Of Advisory Group
NIH Extramural Office Lists Initiatives For Reinvention
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- FDA clears a way for dramatic reduction in animal toxicology studies in cancer
- Is psilocybin heading to a cancer clinic near you?
Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded









